Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

97.84 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Guardant Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
3 Small-Cap Stocks in the Doghouse
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
News headline image
4 Healthcare Stocks With Massive Gains—and More to Come
Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year. 
Via MarketBeat
Topics Artificial Intelligence Economy World Trade
News headline image
The Future of Healthcare: 10 Predictions For The Next Decade
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Earnings Scheduled For February 20, 2025 ↗
 
Via Benzinga
News headline image
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack
Looking back on testing & diagnostics services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Labcorp (NYSE:LH) and its peers. 
Via StockStory
News headline image
Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting... 
Via StockStory
News headline image
1 Healthcare Stock on Our Watchlist and 2 to Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
News headline image
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Quest (NYSE:DGX) and the best and worst... 
Via StockStory
News headline image
1 Stock Under $50 with Solid Fundamentals and 2 to Turn Down
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
Medicare To Reimburse Guardant Health's Shield Colorectal Cancer Test, Analyst Expects $10M In Revenue ↗
CMS approves ADLT status for Guardant Health's Shield test, setting Medicare reimbursement at $1,495. The analyst sees a potential revenue boost from the decision. 
Via Benzinga
News headline image
Korn Ferry Posts Better-Than-Expected Earnings, Joins Bioventus, Endeavour Silver, Vail Resorts And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Healthcare Stocks Doing Well But SMID Biotech Looking A Little Frazzled ↗
Small caps took another step down this past week as geopolitical events dampened sentiment. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Guardant Health’s (NASDAQ:GH) Q4: Beats On Revenue
Diagnostics company Guardant Health (NASDAQ:GH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 30.2% year on year to $201.8 million. Its GAAP loss of $0.90 per share was 12.4%... 
Via StockStory
News headline image
What's Going On With Cancer Diagnostic Firm Guardant Health On Friday? ↗
Guardant Health beat Q4 estimates with a smaller EPS loss and strong revenue growth. Analysts raised price targets, citing momentum and solid financials. 
Via Benzinga
News headline image
Guardant Health Tops Q4 Revenue Forecast ↗
The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses. 
Via The Motley Fool
News headline image
Okla And Rigetti Computing Are Among Top 8 Mid Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio? ↗
Top performers in last week's mid-cap stocks: Oklo Inc., Tempus AI, Himax Tech, Super Group, NuScale Power, WNS Holdings, Guardant Health, Rigetti Computing. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test ↗
Guardant Reveal test receives expanded Medicare coverage for colorectal cancer recurrence monitoring, enhancing revenue potential and clinical adoption. 
Via Benzinga
News headline image
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone ↗
The company is working to expand the uses and reimbursement for its blood-based tests for cancer. 
Via Investor's Business Daily
News headline image
Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? ↗
These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio? 
Via Benzinga
News headline image
Guardant Health Stock Sees RS Rating Jump To 83 ↗
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. 
Via Investor's Business Daily
News headline image
Deciphering Disruption: Inside Cathie Wood's Latest Plays
Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies. 
Via MarketBeat
Topics Artificial Intelligence ETFs
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The rock star money manager is starting to roll with the rallying market. 
Via The Motley Fool
News headline image
Smaller Cap Biotechs Are In Season: How Are We Doing? ↗
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
News headline image
Why Guardant Health Stock Blasted 13% Higher on Thursday ↗
Via The Motley Fool
News headline image
HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop ↗
The company also hiked its outlook for the year and guided to 20% growth in clinical volumes next year. 
Via Investor's Business Daily
News headline image
Why Guardant Health Stock Was the Picture of Health Today ↗
There's nothing like free publicity to help goose the sales of a relatively new product. 
Via The Motley Fool
News headline image
FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test ↗
Exact Sciences' Cologuard Plus test, now FDA-approved, offers a non-invasive screening option for adults 45+ at average risk for colorectal cancer. The test outperformed fecal immunochemical tests in... 
Via Benzinga
News headline image
Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.